Rice David V. 4
4 · COMMUNITY HEALTH SYSTEMS INC · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Community Health Systems (CYH) EVP David Rice Receives Awards
What Happened
David V. Rice, EVP — Clinical Operations & CMO of Community Health Systems (CYH), was granted three equity awards on 2026-06-01 totaling 90,000 shares (three grants of 30,000 each). Each grant shows an acquisition price of $0.00 (typical for restricted stock/RSU awards); no cash was paid. Two of the grants are reported as derivative awards (performance- or time-based RSUs); one appears as a direct restricted stock award subject to time-based vesting.
Key Details
- Transaction date: 2026-06-01; transaction code: A (award/grant). Report filed same day.
- Grants: 3 × 30,000 shares = 90,000 total; acquisition price $0.00; total reported value $0.
- Vesting notes:
- One award vests in three equal time-based increments (1/3 on each of the first, second and third anniversaries) (F1).
- One award is performance-based (2026–2028 performance period): 50% tied to cumulative same-store adjusted EBITDA growth and 50% to cumulative same-store net revenue growth; payout ranges 0%–200% of target and, if earned, vests on 3/1/2029 (F2).
- The third award also vests in 1/3 increments on the first, second and third anniversaries (F3).
- Shares owned after the transaction were not specified in the provided filing.
- No 10b5-1 plan, tax withholding, sale, or cash exercise was indicated in the disclosed transactions.
Context
These awards are compensation grants (not open-market purchases or sales). Time-based RSUs vest over the next three years; the performance RSUs depend on multi-year corporate targets and could range from 0% to 200% of target. Such grants are routine executive compensation and do not by themselves indicate an immediate buy or sell signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-01+30,000→ 30,000 total - Award
Performance Based Restricted
[F2]2026-06-01+30,000→ 30,000 totalExercise: $0.00→ Common Stock (30,000 underlying) - Award
Stock Options (Right to Buy)
[F3]2026-06-01+30,000→ 30,000 totalExercise: $2.75From: 2027-06-01Exp: 2036-05-31→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
- [F2]The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on 3/1/2029, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.
- [F3]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.